Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
NFL
U.S.
2024 Election
Local
World
Science
Technology
AI
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Ozempic can even cut risk of Alzheimer’s disease, study says
Ozempic May Reduce the Risk of Alzheimer’s. That’s Huge for Novo Nordisk.
Ozempic and Wegovy, the two brand names under which the company sells the GLP-1 drug semaglutide, are already blockbusters.
Ozempic can even cut the risk of Alzheimer’s disease, study says
Novo Nordisk’s blockbuster drug Ozempic (NVO) is linked to yet another health benefit. This time it’s lowering the risk of Alzheimer’s disease.
Ozempic linked to lower Alzheimer's risk in people with Type 2 diabetes
Semaglutide, the active ingredient in Ozempic and Wegovy, appeared to reduce the risk of Alzheimer’s disease in people with Type 2 diabetes, according to a study published Thursday in the journal Alzheimer’s & Dementia.
The Economist
16h
GLP-1s like Ozempic are among the most important drug breakthroughs ever
More recently they have become a wildly popular way for people to lose weight. But in March semaglutide (a
GLP-1
receptor ...
Futurism on MSN
20h
The Diet Industry Is Reportedly in Total Meltdown Over GLP-1 Weight Loss Drugs
With weight loss injectables like Ozempic and Mounjaro taking the world by storm, the diet industry is seemingly being left ...
Healthline
2d
How Ozempic, GLP-1 Weight Loss Drugs Affect the Brain to Curb Substance Misuse
A recent study found significant reductions in opioid overdose and alcohol misuse among people taking GLP-1 drugs like ...
The Economist
16h
It’s not just obesity. Drugs like Ozempic will change the world
Already one in eight American adults has been on
glp-1
drugs. Novo Nordisk, maker of semaglutide, branded
Ozempic
for ...
1d
The Maker of Ozempic Is Trying to Block Compounded Versions of Its Blockbuster Drug
Novo Nordisk has asked the FDA to block production of compounded copies of Ozempic, arguing that it’s too difficult to do ...
ABC News
11h
Active ingredient in Ozempic, Wegovy may reduce risk of Alzheimer's disease: Study
However, the exact mechanism behind how
GLP-1
medications reduce Alzheimer's risk is unknown so more research is needed, according to Xu. In this Oct. 31, 2023 file photo, a box of
Ozempic
and ...
7h
Diabetes patients worry about insulin shortages as Ozempic use skyrockets
The insulin is facing supply shortages as diabetes patients increasingly turn to GLP-1 weight loss drugs such as Ozempic and ...
20h
on MSN
Ozempic and Wegovy are trimming waistlines—and showing how quickly U.S. health care can turn into a gold rush
The GLP-1 phenomenon is making the fragmentation and dysfunction of the U.S. health care system even more apparent.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback